Life ScienceCompany
Who owns Smith & Nephew - TransCyte Product Line?
Smith & Nephew - TransCyte Product Line is owned by Shire Regenerative Medicine. It was acquired in 2006.
Smith & Nephew - TransCyte Product Line is owned by Shire Regenerative Medicine. It was acquired in 2006.
| Status | Dates | Investor(s) | |
|---|---|---|---|
| Investment | Exit | ||
| Current | 2006-05-31 | Shire Regenerative Medicine, Inc. | |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
